ACHV · NASDAQ · Biotechnology

Achieve Life Sciences (ACHV)

Develops cytisinicline for nicotine dependence across smoking-cessation and vaping-cessation programs.

$8.21
After hours+0.08 (+0.96%)
At close$8.13(+0.99%)